{"gene":"ARPC5","run_date":"2026-04-28T17:12:37","timeline":{"discoveries":[{"year":2003,"finding":"MAPKAPK2 (downstream of p38 MAPK) directly phosphorylates the A isoform of ARPC5 (p16-Arc) at serine-77; mutation of Ser77 to Ala abolished phosphorylation. MAPKAPK2 also phosphorylates ARPC5 within intact Arp2/3 complexes immunoprecipitated from neutrophil lysates. The B isoform is not a substrate.","method":"In vitro kinase assay with recombinant MAPKAPK2 and neutrophil lysates; 2D electrophoresis/MALDI-MS proteomics; site-directed mutagenesis (S77A); Co-IP of intact Arp2/3 complex","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro phosphorylation assay combined with mutagenesis and complex-level verification","pmids":["12829704"],"is_preprint":false},{"year":2003,"finding":"A second human isoform of ARPC5, termed ARPC5B (ARPC5L), was identified and shown to co-purify with affinity-purified Arp2/3 complex from human neutrophil extract, demonstrating that mammalian cells contain multiple compositionally distinct Arp2/3 complexes. Both isoforms co-localize with the Arp2/3 complex in C2C12 cells.","method":"Affinity purification of Arp2/3 complex; isoform-specific antibodies; immunofluorescence co-localization in C2C12 cells","journal":"Cell motility and the cytoskeleton","confidence":"High","confidence_rationale":"Tier 1-2 — biochemical co-purification with reciprocal antibody validation and cell imaging","pmids":["12451597"],"is_preprint":false},{"year":2011,"finding":"PKC phosphorylates ARPC5 in neointimal smooth muscle cells; phosphoproteomic screening identified ARPC5 as a PKC substrate. RNA silencing of ARPC5 and transfection of a non-phosphorylatable ARPC5 mutant disrupted rear polarization of the MTOC and impaired directional migration, placing ARPC5 downstream of PKC in the regulation of actin and microtubule cytoskeletal organization during SMC migration.","method":"Phosphoproteomic screening and mass spectrometry; siRNA knockdown; non-phosphorylatable ARPC5 mutant transfection; MTOC polarity assay; migration assay","journal":"The American journal of pathology","confidence":"High","confidence_rationale":"Tier 2 — mass-spectrometry-identified phosphorylation confirmed by mutant phenotype with multiple cellular readouts","pmids":["21281821"],"is_preprint":false},{"year":2012,"finding":"ARPC5 is a direct transcriptional/post-transcriptional target of miR-133a in HNSCC cells. Luciferase reporter assay confirmed direct binding of miR-133a to the ARPC5 3'UTR. Silencing ARPC5 reorganizes the actin cytoskeleton and inhibits cell migration and invasion.","method":"Luciferase reporter assay; siRNA knockdown; genome-wide gene expression analysis; cell migration/invasion assays; immunohistochemistry","journal":"International journal of oncology","confidence":"Medium","confidence_rationale":"Tier 2 — direct 3'UTR reporter validation plus functional KD phenotype in multiple cell lines","pmids":["22378351"],"is_preprint":false},{"year":2012,"finding":"ARPC5 (Arpc5) functions as a translational suppressor in male germ cells: it inhibits translation initiation by blocking 80S ribosome formation and facilitates mRNA transport to chromatoid/P bodies. This activity depends on microRNA-dependent regulation of Arpc5 levels; loss of this regulation causes abnormal round spermatid differentiation and impaired fertility.","method":"Genetic loss-of-function in mouse germ cells; polysome profiling; chromatoid body localization assays; fertility phenotype assessment","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal biochemical and cell-biological methods with defined in vivo phenotype","pmids":["22447776"],"is_preprint":false},{"year":2021,"finding":"YAP (but not TAZ) transcriptionally regulates ARPC5 in melanoma cells. Depletion of YAP reduces ARPC5 expression, and ARPC5 is required for YAP-dependent maintenance of focal adhesion numbers, cell invasion, and migration.","method":"RNA-seq after YAP/TAZ depletion; siRNA knockdown of ARPC5; focal adhesion and matrigel invasion assays","journal":"Pigment cell & melanoma research","confidence":"Medium","confidence_rationale":"Tier 2-3 — transcriptomic identification with functional KD rescue experiments","pmids":["34468072"],"is_preprint":false},{"year":2023,"finding":"ARPC5 and ARPC5L (ArpC5 isoforms) differentially regulate Arp2/3-dependent actin protrusion. ArpC5 and ArpC5L both define the structural stability of ArpC1 at branch junctions. The isoforms differentially position Ena/VASP family proteins at protrusions, and Ena/VASP mediates the isoform-specific effects on actin assembly levels and cell migration.","method":"Reverse genetics (isoform-selective knockouts); cryo-electron tomography of branch junctions; FRAP; live-cell imaging; cellular structural biology","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1-2 — cryo-ET structural data combined with reverse genetics and multiple functional assays","pmids":["36662867"],"is_preprint":false},{"year":2023,"finding":"In CD4 T cells, ARPC5 is required for cytoplasmic actin dynamics and DNA replication stress-induced nuclear actin polymerization, while ARPC5L specifically drives TCR-stimulated nuclear actin polymerization. TCR-triggered nuclear actin polymerization proceeds via nuclear calcium-calmodulin signaling and N-WASP upstream of ARPC5L-containing Arp2/3 complexes.","method":"Isoform-specific siRNA knockdown; live imaging of nuclear/cytoplasmic actin; calcium-calmodulin and N-WASP inhibition; T cell activation assays","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 — isoform-selective KD with multiple orthogonal stimuli and pathway epistasis","pmids":["37162507"],"is_preprint":false},{"year":2023,"finding":"Germline biallelic null mutations in ARPC5 disrupt Arp2/3 complex conformation and function across multiple immune cell lineages. Re-expression of ARPC5 in vitro rescues Arp2/3 complex assembly and function. ARPC5 deficiency also selectively impairs IL-6 classical signaling (not trans-signaling), identifying a cytokine-specific downstream consequence.","method":"Patient-derived cells with germline ARPC5 null mutations; in vitro protein reconstitution; Arp2/3 complex functional assays; IL-6 signaling analysis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 — human loss-of-function validated by in vitro reconstitution with multiple orthogonal functional readouts","pmids":["37349293"],"is_preprint":false},{"year":2023,"finding":"KLF4 transcriptionally activates ARPC5 by binding its promoter, and ARPC5 promotes prostate cancer cell migration and invasion by upregulating ADAM17 as a downstream effector. Silencing ARPC5 suppresses ADAM17 expression and reduces tumor growth in xenograft models.","method":"Chromatin immunoprecipitation; luciferase reporter assay; shRNA knockdown; ADAM17 overexpression rescue; xenograft mouse model","journal":"Apoptosis","confidence":"Medium","confidence_rationale":"Tier 2-3 — ChIP and reporter assay identify upstream regulator; downstream pathway confirmed by epistasis knockdown/rescue","pmids":["36881291"],"is_preprint":false},{"year":2023,"finding":"CPEB2 binds ARPC5 mRNA and enhances its stability, thereby increasing ARPC5 protein levels to promote multiple myeloma cell proliferation and angiogenesis. ARPC5 overexpression rescues the suppressive effect of CPEB2 knockdown.","method":"RNA immunoprecipitation; actinomycin D mRNA stability assay; FISH co-localization; siRNA/overexpression rescue experiments","journal":"Journal of orthopaedic surgery and research","confidence":"Medium","confidence_rationale":"Tier 2-3 — RNA-IP and stability assay directly demonstrate post-transcriptional regulation with epistasis rescue","pmids":["37231521"],"is_preprint":false},{"year":2024,"finding":"TAGLN2 protein physically interacts with ARPC5 protein (co-immunoprecipitation confirmed) and positively regulates ARPC5 expression, which in turn activates the MEK/ERK signaling pathway to promote pancreatic cancer cell proliferation, invasion, and metastasis. Silencing ARPC5 reverses the pro-tumorigenic effects of TAGLN2 overexpression.","method":"Co-immunoprecipitation; immunofluorescence; lentiviral knockdown/overexpression; MEK inhibitor (U0126) epistasis; in vivo xenograft","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 3 — direct protein interaction by Co-IP with functional epistasis in vitro and in vivo","pmids":["38744388"],"is_preprint":false},{"year":2025,"finding":"Cryo-EM structures at 2.9-Å resolution reveal that NPF binding to Arp2 is allosterically linked to release of ArpC5's N-terminal tail from Arp2, and to closure of Arp2's ATP-binding cleft and its partial rotation/translation toward the active conformation. This represents an allosteric switch distinct from NPF binding to Arp3 (which releases Arp3's C-terminal tail), together shifting the equilibrium toward Arp2/3 complex activation.","method":"Cryo-EM structure determination (2.9 Å); structural comparison of two states with NPFs bound to different sites","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — high-resolution cryo-EM with two structural states providing direct mechanistic insight","pmids":["40042350"],"is_preprint":false},{"year":2024,"finding":"In muscle cells, Arp2/3 complexes containing Arpc5 (but not Arpc5l) regulate actomyosin cortex integrity beneath the plasma membrane, acting as a gatekeeper for membrane availability required for t-tubule growth. Postnatal ablation of Arpc5 in myofibers causes enlarged t-tubules, impaired calcium release synchronization, and muscle fatigue.","method":"Conditional KO of Arpc5 in myofibers; live imaging of t-tubules; calcium imaging; muscle fatigue measurements","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — isoform-specific KO with multiple orthogonal cellular and physiological phenotypes, but preprint","pmids":["bio_10.1101_2024.08.13.607563"],"is_preprint":true},{"year":2024,"finding":"Loss of Arpc5 (but not Arpc5l) in the murine hematopoietic system causes intestinal inflammation by impairing macrophage phagocytosis and killing of intracellular bacteria, demonstrating that Arpc5-containing Arp2/3 complexes are specifically required for mononuclear phagocyte function and host-microbiota homeostasis.","method":"Hematopoietic-specific Arpc5 KO mouse; phagocytosis and bacterial killing assays; histopathology; isoform-selective comparison","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — isoform-selective in vivo KO with defined cellular mechanistic readout, but preprint","pmids":["bio_10.1101_2024.07.18.604111"],"is_preprint":true}],"current_model":"ARPC5 is the smallest subunit of the seven-member Arp2/3 complex whose N-terminal tail contacts Arp2 and is released upon NPF binding as part of an allosteric activation mechanism; it exists as two isoforms (ARPC5/ARPC5A and ARPC5L/ARPC5B) that incorporate into compositionally distinct Arp2/3 complexes with non-redundant roles — ARPC5 drives cytoplasmic actin dynamics, macrophage phagocytosis, muscle cortex integrity, and DNA-stress-induced nuclear actin polymerization, while ARPC5L preferentially mediates TCR-triggered nuclear actin polymerization — and ARPC5 activity is modulated post-translationally by MAPKAPK2-mediated phosphorylation at Ser77 and by PKC-dependent phosphorylation that controls MTOC polarity during directed cell migration."},"narrative":{"teleology":[{"year":2003,"claim":"The discovery that mammalian cells harbor two ARPC5 isoforms (ARPC5 and ARPC5L) that each co-purify with Arp2/3 complexes established that compositionally distinct Arp2/3 complexes exist, raising the question of whether these isoforms have specialized functions.","evidence":"Affinity purification of Arp2/3 from neutrophil extract with isoform-specific antibodies and co-localization in C2C12 cells","pmids":["12451597"],"confidence":"High","gaps":["Functional differences between ARPC5- and ARPC5L-containing complexes were not yet addressed","Tissue-specific expression patterns not characterized"]},{"year":2003,"claim":"Identifying MAPKAPK2-mediated phosphorylation of ARPC5 at Ser77 — specific to the A isoform and occurring within intact Arp2/3 complexes — established the first post-translational regulatory input into the Arp2/3 complex through its smallest subunit.","evidence":"In vitro kinase assay with recombinant MAPKAPK2; S77A mutagenesis; Co-IP of intact complex from neutrophil lysates","pmids":["12829704"],"confidence":"High","gaps":["Functional consequence of Ser77 phosphorylation on actin nucleation or cell behavior was not determined","In vivo phosphorylation kinetics unknown"]},{"year":2011,"claim":"Demonstrating that PKC phosphorylates ARPC5 to control MTOC polarity and directional migration in smooth muscle cells established a second kinase pathway regulating ARPC5 and linked Arp2/3 to microtubule organization during cell migration.","evidence":"Phosphoproteomic MS identification; non-phosphorylatable mutant disrupts MTOC polarity and migration in neointimal SMCs","pmids":["21281821"],"confidence":"High","gaps":["Specific phosphorylation site(s) targeted by PKC not mapped to single residue","Whether PKC acts on ARPC5 within assembled Arp2/3 or free subunit not resolved"]},{"year":2012,"claim":"An unexpected non-cytoskeletal role was revealed when ARPC5 was shown to suppress translation initiation and facilitate mRNA transport to chromatoid bodies in male germ cells, with loss of function impairing spermatid differentiation and fertility.","evidence":"Genetic loss-of-function in mouse germ cells; polysome profiling; chromatoid body localization; fertility phenotyping","pmids":["22447776"],"confidence":"High","gaps":["Whether translational suppression requires Arp2/3 complex assembly or is an independent ARPC5 function remains unclear","Mechanism of 80S formation block not structurally defined"]},{"year":2023,"claim":"Cryo-electron tomography of branch junctions and isoform-selective knockouts revealed that ARPC5 and ARPC5L differentially stabilize ArpC1 at branches and differentially position Ena/VASP proteins, explaining their non-redundant effects on actin assembly and migration.","evidence":"Isoform-selective KO cells; cryo-ET of branch junctions; FRAP and live-cell imaging","pmids":["36662867"],"confidence":"High","gaps":["How Ena/VASP recruitment is differentially specified at the molecular level is not resolved","Whether differential branch stability translates to distinct network architectures in vivo remains untested"]},{"year":2023,"claim":"Isoform-specific knockdowns in CD4 T cells showed that ARPC5 drives cytoplasmic actin dynamics and DNA-damage-induced nuclear actin polymerization, whereas ARPC5L mediates TCR-triggered nuclear actin polymerization through nuclear calcium–calmodulin and N-WASP, establishing stimulus-specific nuclear roles for each isoform.","evidence":"Isoform-specific siRNA in T cells; live nuclear/cytoplasmic actin imaging; pathway epistasis with calmodulin and N-WASP inhibitors","pmids":["37162507"],"confidence":"High","gaps":["How ARPC5L-containing complexes are selectively imported into the nucleus is unknown","Downstream nuclear targets of isoform-specific actin polymerization not identified"]},{"year":2023,"claim":"Human germline biallelic ARPC5 null mutations proved that ARPC5 is essential for Arp2/3 complex integrity across immune lineages, with reconstitution rescuing complex assembly, and revealed a selective impairment of IL-6 classical (but not trans-) signaling, linking ARPC5 deficiency to immune dysregulation.","evidence":"Patient-derived cells with null ARPC5; in vitro reconstitution rescue; IL-6 classical vs. trans-signaling assays","pmids":["37349293"],"confidence":"High","gaps":["Mechanism by which ARPC5 loss selectively impairs IL-6 classical signaling is not defined","Full clinical spectrum of ARPC5 deficiency not delineated"]},{"year":2025,"claim":"High-resolution cryo-EM structures revealed the allosteric mechanism by which NPF binding to Arp2 releases ARPC5's N-terminal tail, closes Arp2's ATP cleft, and initiates partial rotation toward the active state — mechanistically distinct from NPF binding at Arp3.","evidence":"Cryo-EM at 2.9 Å resolution comparing two NPF-bound structural states","pmids":["40042350"],"confidence":"High","gaps":["Whether Ser77 phosphorylation by MAPKAPK2 modulates N-terminal tail release or allosteric activation has not been tested structurally","Full activation trajectory including short-pitch dimer formation not captured"]},{"year":null,"claim":"The functional consequences of ARPC5 Ser77 phosphorylation on Arp2/3 activation kinetics and branched actin nucleation remain unknown, and the structural basis for isoform-selective nuclear import and stimulus-specific actin polymerization has not been determined.","evidence":"","pmids":[],"confidence":"High","gaps":["No in vitro reconstitution of phospho-ARPC5 effects on actin nucleation","Structural basis for ARPC5 vs. ARPC5L functional divergence at atomic resolution not established","Whether the translational suppressor role in germ cells depends on intact Arp2/3 complex remains untested"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008092","term_label":"cytoskeletal protein binding","supporting_discovery_ids":[6,7,12,13]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[6,8,12]}],"localization":[{"term_id":"GO:0005856","term_label":"cytoskeleton","supporting_discovery_ids":[1,6,7,13]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[7]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[7]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[13]}],"pathway":[{"term_id":"R-HSA-1500931","term_label":"Cell-Cell communication","supporting_discovery_ids":[6,7]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[7,8,14]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,2,8]}],"complexes":["Arp2/3 complex"],"partners":["ARPC1","ARP2","ARPC5L","MAPKAPK2","TAGLN2","ADAM17"],"other_free_text":[]},"mechanistic_narrative":"ARPC5 encodes the smallest subunit (p16-Arc) of the Arp2/3 complex and is essential for branched actin nucleation, with its N-terminal tail contacting Arp2 and undergoing allosteric release upon NPF binding to shift the complex toward its active conformation [PMID:40042350]. ARPC5 and its paralog ARPC5L incorporate into compositionally distinct Arp2/3 complexes with non-redundant cellular functions: ARPC5-containing complexes preferentially drive cytoplasmic actin dynamics, DNA-replication-stress-induced nuclear actin polymerization, and macrophage phagocytosis, whereas ARPC5L-containing complexes mediate TCR-triggered nuclear actin polymerization via nuclear calcium–calmodulin and N-WASP signaling [PMID:36662867, PMID:37162507]. ARPC5 activity is regulated post-translationally by MAPKAPK2 phosphorylation at Ser77 and by PKC-dependent phosphorylation that controls MTOC polarity during directed cell migration [PMID:12829704, PMID:21281821]. Germline biallelic null mutations in ARPC5 disrupt Arp2/3 complex conformation and function across immune cell lineages and selectively impair IL-6 classical signaling, establishing ARPC5 deficiency as a cause of immune dysregulation [PMID:37349293]."},"prefetch_data":{"uniprot":{"accession":"O15511","full_name":"Actin-related protein 2/3 complex subunit 5","aliases":["Arp2/3 complex 16 kDa subunit","p16-ARC"],"length_aa":151,"mass_kda":16.3,"function":"Component of the Arp2/3 complex, a multiprotein complex that mediates actin polymerization upon stimulation by nucleation-promoting factor (NPF) (PubMed:9230079). The Arp2/3 complex mediates the formation of branched actin networks in the cytoplasm, providing the force for cell motility (PubMed:9230079). In addition to its role in the cytoplasmic cytoskeleton, the Arp2/3 complex also promotes actin polymerization in the nucleus, thereby regulating gene transcription and repair of damaged DNA (PubMed:29925947). The Arp2/3 complex promotes homologous recombination (HR) repair in response to DNA damage by promoting nuclear actin polymerization, leading to drive motility of double-strand breaks (DSBs) (PubMed:29925947)","subcellular_location":"Cytoplasm, cytoskeleton; Cell projection; Nucleus","url":"https://www.uniprot.org/uniprotkb/O15511/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/ARPC5","classification":"Not Classified","n_dependent_lines":49,"n_total_lines":1208,"dependency_fraction":0.04056291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"ACTR2","stoichiometry":10.0},{"gene":"ARPC2","stoichiometry":10.0},{"gene":"ARPC3","stoichiometry":10.0},{"gene":"USP22","stoichiometry":4.0},{"gene":"ACTG1","stoichiometry":0.2},{"gene":"ACTN4","stoichiometry":0.2},{"gene":"CALD1","stoichiometry":0.2},{"gene":"CALM3","stoichiometry":0.2},{"gene":"CAPZB","stoichiometry":0.2},{"gene":"CDC42","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/ARPC5","total_profiled":1310},"omim":[{"mim_id":"621450","title":"ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 5-LIKE; ARPC5L","url":"https://www.omim.org/entry/621450"},{"mim_id":"620565","title":"IMMUNODEFICIENCY 113 WITH AUTOIMMUNITY AND AUTOINFLAMMATION; IMD113","url":"https://www.omim.org/entry/620565"},{"mim_id":"604227","title":"ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 5; ARPC5","url":"https://www.omim.org/entry/604227"},{"mim_id":"604226","title":"ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 4; ARPC4","url":"https://www.omim.org/entry/604226"},{"mim_id":"604225","title":"ACTIN-RELATED PROTEIN 2/3 COMPLEX, SUBUNIT 3; ARPC3","url":"https://www.omim.org/entry/604225"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Vesicles","reliability":"Approved"},{"location":"Plasma membrane","reliability":"Approved"},{"location":"Cell Junctions","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/ARPC5"},"hgnc":{"alias_symbol":["p16-Arc","ARC16","dJ127C7.3"],"prev_symbol":[]},"alphafold":{"accession":"O15511","domains":[{"cath_id":"1.25.40.190","chopping":"35-145","consensus_level":"high","plddt":96.279,"start":35,"end":145}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/O15511","model_url":"https://alphafold.ebi.ac.uk/files/AF-O15511-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-O15511-F1-predicted_aligned_error_v6.png","plddt_mean":92.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=ARPC5","jax_strain_url":"https://www.jax.org/strain/search?query=ARPC5"},"sequence":{"accession":"O15511","fasta_url":"https://rest.uniprot.org/uniprotkb/O15511.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/O15511/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/O15511"}},"corpus_meta":[{"pmid":"22378351","id":"PMC_22378351","title":"Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma.","date":"2012","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22378351","citation_count":74,"is_preprint":false},{"pmid":"12829704","id":"PMC_12829704","title":"Identification of the p16-Arc subunit of the Arp 2/3 complex as a substrate of MAPK-activated protein kinase 2 by proteomic analysis.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12829704","citation_count":47,"is_preprint":false},{"pmid":"12451597","id":"PMC_12451597","title":"Identification and characterisation of a novel human isoform of Arp2/3 complex subunit p16-ARC/ARPC5.","date":"2003","source":"Cell motility and the cytoskeleton","url":"https://pubmed.ncbi.nlm.nih.gov/12451597","citation_count":35,"is_preprint":false},{"pmid":"21281821","id":"PMC_21281821","title":"Rear polarization of the microtubule-organizing center in neointimal smooth muscle cells depends on PKCα, ARPC5, and RHAMM.","date":"2011","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/21281821","citation_count":30,"is_preprint":false},{"pmid":"22447776","id":"PMC_22447776","title":"Interaction between microRNAs and actin-associated protein Arpc5 regulates translational suppression during male germ cell differentiation.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/22447776","citation_count":28,"is_preprint":false},{"pmid":"34468072","id":"PMC_34468072","title":"YAP facilitates melanoma migration through regulation of actin-related protein 2/3 complex subunit 5 (ARPC5).","date":"2021","source":"Pigment cell & melanoma research","url":"https://pubmed.ncbi.nlm.nih.gov/34468072","citation_count":21,"is_preprint":false},{"pmid":"36662867","id":"PMC_36662867","title":"ArpC5 isoforms regulate Arp2/3 complex-dependent protrusion through differential Ena/VASP positioning.","date":"2023","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/36662867","citation_count":19,"is_preprint":false},{"pmid":"37162507","id":"PMC_37162507","title":"ARPC5 isoforms and their regulation by calcium-calmodulin-N-WASP drive distinct Arp2/3-dependent actin remodeling events in CD4 T cells.","date":"2023","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/37162507","citation_count":19,"is_preprint":false},{"pmid":"37349293","id":"PMC_37349293","title":"Inherited ARPC5 mutations cause an actinopathy impairing cell motility and disrupting cytokine signaling.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37349293","citation_count":12,"is_preprint":false},{"pmid":"37231521","id":"PMC_37231521","title":"CPEB2 enhances cell growth and angiogenesis by upregulating ARPC5 mRNA stability in multiple myeloma.","date":"2023","source":"Journal of orthopaedic surgery and research","url":"https://pubmed.ncbi.nlm.nih.gov/37231521","citation_count":8,"is_preprint":false},{"pmid":"23459330","id":"PMC_23459330","title":"Effects of hypothyroidism on expression of CRMP2B and ARPC5 during development of the rat frontal cortex.","date":"2013","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/23459330","citation_count":8,"is_preprint":false},{"pmid":"36881291","id":"PMC_36881291","title":"ARPC5 is transcriptionally activated by KLF4, and promotes cell migration and invasion in prostate cancer via up-regulating ADAM17 : ARPC5 serves as an oncogene in prostate cancer.","date":"2023","source":"Apoptosis : an international journal on programmed cell death","url":"https://pubmed.ncbi.nlm.nih.gov/36881291","citation_count":8,"is_preprint":false},{"pmid":"36605483","id":"PMC_36605483","title":"Long noncoding RNA DSCR8 promotes the proliferation of liver cancer cells and inhibits apoptosis via the miR-22-3p/ARPC5 Axis.","date":"2023","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/36605483","citation_count":6,"is_preprint":false},{"pmid":"38744388","id":"PMC_38744388","title":"TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, invasion, and metastasis of pancreatic cancer cells.","date":"2024","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/38744388","citation_count":4,"is_preprint":false},{"pmid":"40042350","id":"PMC_40042350","title":"NPF binding to Arp2 is allosterically linked to the release of ArpC5's N-terminal tail and conformational changes in Arp2/3 complex.","date":"2025","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/40042350","citation_count":4,"is_preprint":false},{"pmid":"40669463","id":"PMC_40669463","title":"PIF4 controls autophagy during hypocotyl response to elevated ambient temperatures via ArpC5 in Arabidopsis.","date":"2025","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/40669463","citation_count":2,"is_preprint":false},{"pmid":"37081667","id":"PMC_37081667","title":"MiR-145 regulates steroidogenesis in mouse primary granulosa cells by targeting Arpc5 and subsequent cytoskeleton remodeling.","date":"2023","source":"The Journal of reproduction and development","url":"https://pubmed.ncbi.nlm.nih.gov/37081667","citation_count":2,"is_preprint":false},{"pmid":"41403630","id":"PMC_41403630","title":"LncRNA NEAT1 contributes to multiple myeloma progression via upregulating ARPC5 by sponging miR-133a.","date":"2024","source":"Archives of medical science : AMS","url":"https://pubmed.ncbi.nlm.nih.gov/41403630","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.08.07.669089","title":"Integrative analysis of gene networks associated with adipose and muscle traits in Hanwoo steers","date":"2025-08-10","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.07.669089","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.08.13.607563","title":"The actomyosin cortex controls t-tubule remodeling in muscle","date":"2024-08-13","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.13.607563","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.07.18.604111","title":"Branched actin networks mediate macrophage-dependent host microbiota homeostasis","date":"2024-07-18","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.18.604111","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":11237,"output_tokens":3848,"usd":0.045715},"stage2":{"model":"claude-opus-4-6","input_tokens":7260,"output_tokens":2531,"usd":0.149363},"total_usd":0.195078,"stage1_batch_id":"msgbatch_01TqNM6p6FsoMBT2jzQTwKBr","stage2_batch_id":"msgbatch_01Ya473eco8sTHbvRymQaU8o","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"MAPKAPK2 (downstream of p38 MAPK) directly phosphorylates the A isoform of ARPC5 (p16-Arc) at serine-77; mutation of Ser77 to Ala abolished phosphorylation. MAPKAPK2 also phosphorylates ARPC5 within intact Arp2/3 complexes immunoprecipitated from neutrophil lysates. The B isoform is not a substrate.\",\n      \"method\": \"In vitro kinase assay with recombinant MAPKAPK2 and neutrophil lysates; 2D electrophoresis/MALDI-MS proteomics; site-directed mutagenesis (S77A); Co-IP of intact Arp2/3 complex\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro phosphorylation assay combined with mutagenesis and complex-level verification\",\n      \"pmids\": [\"12829704\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"A second human isoform of ARPC5, termed ARPC5B (ARPC5L), was identified and shown to co-purify with affinity-purified Arp2/3 complex from human neutrophil extract, demonstrating that mammalian cells contain multiple compositionally distinct Arp2/3 complexes. Both isoforms co-localize with the Arp2/3 complex in C2C12 cells.\",\n      \"method\": \"Affinity purification of Arp2/3 complex; isoform-specific antibodies; immunofluorescence co-localization in C2C12 cells\",\n      \"journal\": \"Cell motility and the cytoskeleton\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — biochemical co-purification with reciprocal antibody validation and cell imaging\",\n      \"pmids\": [\"12451597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PKC phosphorylates ARPC5 in neointimal smooth muscle cells; phosphoproteomic screening identified ARPC5 as a PKC substrate. RNA silencing of ARPC5 and transfection of a non-phosphorylatable ARPC5 mutant disrupted rear polarization of the MTOC and impaired directional migration, placing ARPC5 downstream of PKC in the regulation of actin and microtubule cytoskeletal organization during SMC migration.\",\n      \"method\": \"Phosphoproteomic screening and mass spectrometry; siRNA knockdown; non-phosphorylatable ARPC5 mutant transfection; MTOC polarity assay; migration assay\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mass-spectrometry-identified phosphorylation confirmed by mutant phenotype with multiple cellular readouts\",\n      \"pmids\": [\"21281821\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ARPC5 is a direct transcriptional/post-transcriptional target of miR-133a in HNSCC cells. Luciferase reporter assay confirmed direct binding of miR-133a to the ARPC5 3'UTR. Silencing ARPC5 reorganizes the actin cytoskeleton and inhibits cell migration and invasion.\",\n      \"method\": \"Luciferase reporter assay; siRNA knockdown; genome-wide gene expression analysis; cell migration/invasion assays; immunohistochemistry\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct 3'UTR reporter validation plus functional KD phenotype in multiple cell lines\",\n      \"pmids\": [\"22378351\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"ARPC5 (Arpc5) functions as a translational suppressor in male germ cells: it inhibits translation initiation by blocking 80S ribosome formation and facilitates mRNA transport to chromatoid/P bodies. This activity depends on microRNA-dependent regulation of Arpc5 levels; loss of this regulation causes abnormal round spermatid differentiation and impaired fertility.\",\n      \"method\": \"Genetic loss-of-function in mouse germ cells; polysome profiling; chromatoid body localization assays; fertility phenotype assessment\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal biochemical and cell-biological methods with defined in vivo phenotype\",\n      \"pmids\": [\"22447776\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"YAP (but not TAZ) transcriptionally regulates ARPC5 in melanoma cells. Depletion of YAP reduces ARPC5 expression, and ARPC5 is required for YAP-dependent maintenance of focal adhesion numbers, cell invasion, and migration.\",\n      \"method\": \"RNA-seq after YAP/TAZ depletion; siRNA knockdown of ARPC5; focal adhesion and matrigel invasion assays\",\n      \"journal\": \"Pigment cell & melanoma research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — transcriptomic identification with functional KD rescue experiments\",\n      \"pmids\": [\"34468072\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"ARPC5 and ARPC5L (ArpC5 isoforms) differentially regulate Arp2/3-dependent actin protrusion. ArpC5 and ArpC5L both define the structural stability of ArpC1 at branch junctions. The isoforms differentially position Ena/VASP family proteins at protrusions, and Ena/VASP mediates the isoform-specific effects on actin assembly levels and cell migration.\",\n      \"method\": \"Reverse genetics (isoform-selective knockouts); cryo-electron tomography of branch junctions; FRAP; live-cell imaging; cellular structural biology\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — cryo-ET structural data combined with reverse genetics and multiple functional assays\",\n      \"pmids\": [\"36662867\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In CD4 T cells, ARPC5 is required for cytoplasmic actin dynamics and DNA replication stress-induced nuclear actin polymerization, while ARPC5L specifically drives TCR-stimulated nuclear actin polymerization. TCR-triggered nuclear actin polymerization proceeds via nuclear calcium-calmodulin signaling and N-WASP upstream of ARPC5L-containing Arp2/3 complexes.\",\n      \"method\": \"Isoform-specific siRNA knockdown; live imaging of nuclear/cytoplasmic actin; calcium-calmodulin and N-WASP inhibition; T cell activation assays\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — isoform-selective KD with multiple orthogonal stimuli and pathway epistasis\",\n      \"pmids\": [\"37162507\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Germline biallelic null mutations in ARPC5 disrupt Arp2/3 complex conformation and function across multiple immune cell lineages. Re-expression of ARPC5 in vitro rescues Arp2/3 complex assembly and function. ARPC5 deficiency also selectively impairs IL-6 classical signaling (not trans-signaling), identifying a cytokine-specific downstream consequence.\",\n      \"method\": \"Patient-derived cells with germline ARPC5 null mutations; in vitro protein reconstitution; Arp2/3 complex functional assays; IL-6 signaling analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — human loss-of-function validated by in vitro reconstitution with multiple orthogonal functional readouts\",\n      \"pmids\": [\"37349293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"KLF4 transcriptionally activates ARPC5 by binding its promoter, and ARPC5 promotes prostate cancer cell migration and invasion by upregulating ADAM17 as a downstream effector. Silencing ARPC5 suppresses ADAM17 expression and reduces tumor growth in xenograft models.\",\n      \"method\": \"Chromatin immunoprecipitation; luciferase reporter assay; shRNA knockdown; ADAM17 overexpression rescue; xenograft mouse model\",\n      \"journal\": \"Apoptosis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — ChIP and reporter assay identify upstream regulator; downstream pathway confirmed by epistasis knockdown/rescue\",\n      \"pmids\": [\"36881291\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CPEB2 binds ARPC5 mRNA and enhances its stability, thereby increasing ARPC5 protein levels to promote multiple myeloma cell proliferation and angiogenesis. ARPC5 overexpression rescues the suppressive effect of CPEB2 knockdown.\",\n      \"method\": \"RNA immunoprecipitation; actinomycin D mRNA stability assay; FISH co-localization; siRNA/overexpression rescue experiments\",\n      \"journal\": \"Journal of orthopaedic surgery and research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — RNA-IP and stability assay directly demonstrate post-transcriptional regulation with epistasis rescue\",\n      \"pmids\": [\"37231521\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"TAGLN2 protein physically interacts with ARPC5 protein (co-immunoprecipitation confirmed) and positively regulates ARPC5 expression, which in turn activates the MEK/ERK signaling pathway to promote pancreatic cancer cell proliferation, invasion, and metastasis. Silencing ARPC5 reverses the pro-tumorigenic effects of TAGLN2 overexpression.\",\n      \"method\": \"Co-immunoprecipitation; immunofluorescence; lentiviral knockdown/overexpression; MEK inhibitor (U0126) epistasis; in vivo xenograft\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — direct protein interaction by Co-IP with functional epistasis in vitro and in vivo\",\n      \"pmids\": [\"38744388\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Cryo-EM structures at 2.9-Å resolution reveal that NPF binding to Arp2 is allosterically linked to release of ArpC5's N-terminal tail from Arp2, and to closure of Arp2's ATP-binding cleft and its partial rotation/translation toward the active conformation. This represents an allosteric switch distinct from NPF binding to Arp3 (which releases Arp3's C-terminal tail), together shifting the equilibrium toward Arp2/3 complex activation.\",\n      \"method\": \"Cryo-EM structure determination (2.9 Å); structural comparison of two states with NPFs bound to different sites\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution cryo-EM with two structural states providing direct mechanistic insight\",\n      \"pmids\": [\"40042350\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In muscle cells, Arp2/3 complexes containing Arpc5 (but not Arpc5l) regulate actomyosin cortex integrity beneath the plasma membrane, acting as a gatekeeper for membrane availability required for t-tubule growth. Postnatal ablation of Arpc5 in myofibers causes enlarged t-tubules, impaired calcium release synchronization, and muscle fatigue.\",\n      \"method\": \"Conditional KO of Arpc5 in myofibers; live imaging of t-tubules; calcium imaging; muscle fatigue measurements\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — isoform-specific KO with multiple orthogonal cellular and physiological phenotypes, but preprint\",\n      \"pmids\": [\"bio_10.1101_2024.08.13.607563\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Loss of Arpc5 (but not Arpc5l) in the murine hematopoietic system causes intestinal inflammation by impairing macrophage phagocytosis and killing of intracellular bacteria, demonstrating that Arpc5-containing Arp2/3 complexes are specifically required for mononuclear phagocyte function and host-microbiota homeostasis.\",\n      \"method\": \"Hematopoietic-specific Arpc5 KO mouse; phagocytosis and bacterial killing assays; histopathology; isoform-selective comparison\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — isoform-selective in vivo KO with defined cellular mechanistic readout, but preprint\",\n      \"pmids\": [\"bio_10.1101_2024.07.18.604111\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"ARPC5 is the smallest subunit of the seven-member Arp2/3 complex whose N-terminal tail contacts Arp2 and is released upon NPF binding as part of an allosteric activation mechanism; it exists as two isoforms (ARPC5/ARPC5A and ARPC5L/ARPC5B) that incorporate into compositionally distinct Arp2/3 complexes with non-redundant roles — ARPC5 drives cytoplasmic actin dynamics, macrophage phagocytosis, muscle cortex integrity, and DNA-stress-induced nuclear actin polymerization, while ARPC5L preferentially mediates TCR-triggered nuclear actin polymerization — and ARPC5 activity is modulated post-translationally by MAPKAPK2-mediated phosphorylation at Ser77 and by PKC-dependent phosphorylation that controls MTOC polarity during directed cell migration.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"ARPC5 encodes the smallest subunit (p16-Arc) of the Arp2/3 complex and is essential for branched actin nucleation, with its N-terminal tail contacting Arp2 and undergoing allosteric release upon NPF binding to shift the complex toward its active conformation [PMID:40042350]. ARPC5 and its paralog ARPC5L incorporate into compositionally distinct Arp2/3 complexes with non-redundant cellular functions: ARPC5-containing complexes preferentially drive cytoplasmic actin dynamics, DNA-replication-stress-induced nuclear actin polymerization, and macrophage phagocytosis, whereas ARPC5L-containing complexes mediate TCR-triggered nuclear actin polymerization via nuclear calcium–calmodulin and N-WASP signaling [PMID:36662867, PMID:37162507]. ARPC5 activity is regulated post-translationally by MAPKAPK2 phosphorylation at Ser77 and by PKC-dependent phosphorylation that controls MTOC polarity during directed cell migration [PMID:12829704, PMID:21281821]. Germline biallelic null mutations in ARPC5 disrupt Arp2/3 complex conformation and function across immune cell lineages and selectively impair IL-6 classical signaling, establishing ARPC5 deficiency as a cause of immune dysregulation [PMID:37349293].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"The discovery that mammalian cells harbor two ARPC5 isoforms (ARPC5 and ARPC5L) that each co-purify with Arp2/3 complexes established that compositionally distinct Arp2/3 complexes exist, raising the question of whether these isoforms have specialized functions.\",\n      \"evidence\": \"Affinity purification of Arp2/3 from neutrophil extract with isoform-specific antibodies and co-localization in C2C12 cells\",\n      \"pmids\": [\"12451597\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional differences between ARPC5- and ARPC5L-containing complexes were not yet addressed\", \"Tissue-specific expression patterns not characterized\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identifying MAPKAPK2-mediated phosphorylation of ARPC5 at Ser77 — specific to the A isoform and occurring within intact Arp2/3 complexes — established the first post-translational regulatory input into the Arp2/3 complex through its smallest subunit.\",\n      \"evidence\": \"In vitro kinase assay with recombinant MAPKAPK2; S77A mutagenesis; Co-IP of intact complex from neutrophil lysates\",\n      \"pmids\": [\"12829704\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of Ser77 phosphorylation on actin nucleation or cell behavior was not determined\", \"In vivo phosphorylation kinetics unknown\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Demonstrating that PKC phosphorylates ARPC5 to control MTOC polarity and directional migration in smooth muscle cells established a second kinase pathway regulating ARPC5 and linked Arp2/3 to microtubule organization during cell migration.\",\n      \"evidence\": \"Phosphoproteomic MS identification; non-phosphorylatable mutant disrupts MTOC polarity and migration in neointimal SMCs\",\n      \"pmids\": [\"21281821\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific phosphorylation site(s) targeted by PKC not mapped to single residue\", \"Whether PKC acts on ARPC5 within assembled Arp2/3 or free subunit not resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"An unexpected non-cytoskeletal role was revealed when ARPC5 was shown to suppress translation initiation and facilitate mRNA transport to chromatoid bodies in male germ cells, with loss of function impairing spermatid differentiation and fertility.\",\n      \"evidence\": \"Genetic loss-of-function in mouse germ cells; polysome profiling; chromatoid body localization; fertility phenotyping\",\n      \"pmids\": [\"22447776\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether translational suppression requires Arp2/3 complex assembly or is an independent ARPC5 function remains unclear\", \"Mechanism of 80S formation block not structurally defined\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Cryo-electron tomography of branch junctions and isoform-selective knockouts revealed that ARPC5 and ARPC5L differentially stabilize ArpC1 at branches and differentially position Ena/VASP proteins, explaining their non-redundant effects on actin assembly and migration.\",\n      \"evidence\": \"Isoform-selective KO cells; cryo-ET of branch junctions; FRAP and live-cell imaging\",\n      \"pmids\": [\"36662867\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Ena/VASP recruitment is differentially specified at the molecular level is not resolved\", \"Whether differential branch stability translates to distinct network architectures in vivo remains untested\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Isoform-specific knockdowns in CD4 T cells showed that ARPC5 drives cytoplasmic actin dynamics and DNA-damage-induced nuclear actin polymerization, whereas ARPC5L mediates TCR-triggered nuclear actin polymerization through nuclear calcium–calmodulin and N-WASP, establishing stimulus-specific nuclear roles for each isoform.\",\n      \"evidence\": \"Isoform-specific siRNA in T cells; live nuclear/cytoplasmic actin imaging; pathway epistasis with calmodulin and N-WASP inhibitors\",\n      \"pmids\": [\"37162507\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ARPC5L-containing complexes are selectively imported into the nucleus is unknown\", \"Downstream nuclear targets of isoform-specific actin polymerization not identified\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Human germline biallelic ARPC5 null mutations proved that ARPC5 is essential for Arp2/3 complex integrity across immune lineages, with reconstitution rescuing complex assembly, and revealed a selective impairment of IL-6 classical (but not trans-) signaling, linking ARPC5 deficiency to immune dysregulation.\",\n      \"evidence\": \"Patient-derived cells with null ARPC5; in vitro reconstitution rescue; IL-6 classical vs. trans-signaling assays\",\n      \"pmids\": [\"37349293\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which ARPC5 loss selectively impairs IL-6 classical signaling is not defined\", \"Full clinical spectrum of ARPC5 deficiency not delineated\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"High-resolution cryo-EM structures revealed the allosteric mechanism by which NPF binding to Arp2 releases ARPC5's N-terminal tail, closes Arp2's ATP cleft, and initiates partial rotation toward the active state — mechanistically distinct from NPF binding at Arp3.\",\n      \"evidence\": \"Cryo-EM at 2.9 Å resolution comparing two NPF-bound structural states\",\n      \"pmids\": [\"40042350\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether Ser77 phosphorylation by MAPKAPK2 modulates N-terminal tail release or allosteric activation has not been tested structurally\", \"Full activation trajectory including short-pitch dimer formation not captured\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"The functional consequences of ARPC5 Ser77 phosphorylation on Arp2/3 activation kinetics and branched actin nucleation remain unknown, and the structural basis for isoform-selective nuclear import and stimulus-specific actin polymerization has not been determined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No in vitro reconstitution of phospho-ARPC5 effects on actin nucleation\", \"Structural basis for ARPC5 vs. ARPC5L functional divergence at atomic resolution not established\", \"Whether the translational suppressor role in germ cells depends on intact Arp2/3 complex remains untested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008092\", \"supporting_discovery_ids\": [6, 7, 12, 13]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [6, 8, 12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005856\", \"supporting_discovery_ids\": [1, 6, 7, 13]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [7]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [13]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1500931\", \"supporting_discovery_ids\": [6, 7]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [7, 8, 14]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 2, 8]}\n    ],\n    \"complexes\": [\"Arp2/3 complex\"],\n    \"partners\": [\"ARPC1\", \"ARP2\", \"ARPC5L\", \"MAPKAPK2\", \"TAGLN2\", \"ADAM17\"],\n    \"other_free_text\": []\n  }\n}\n```"}